This protocol is judged by an institutional overview board, an impartial team that critiques any clinical trials involving individuals. If a analyze entails a Plan I drug, when the board approves the protocol as ethical, the scientists need to submit an application for an investigational new drug (IND) selection from the FDA.“It’s crucial to ta